We found a gap in the mass-production release: one or more controls related to trial acceptance, capability, and unresolved risks do not match the approved requirement.

PCBA Engineering & NPIMass Production ReleaseB1professional

เราพบ Gap ในการ Release Mass Production: การควบคุมบางรายการที่เกี่ยวกับ ผล Trial, Capability และความเสี่ยงที่ยังเปิดอยู่ ไม่ตรงกับข้อกำหนดที่อนุมัติ

แกะรูปประโยค

สถานการณ์ / Intent

Problem statement

Grammar / Pattern

past simple + present consequence

คำศัพท์สำคัญ

mass-production release; trial acceptance, capability, and unresolved risks

ระดับภาษา

B1 · professional

ใช้ประโยคนี้อย่างไร

รูปแบบ Problem Statement ที่ดีควรบอกสิ่งที่พบและสิ่งที่ควรเป็น โดยยังไม่รีบสรุป Root Cause หากหลักฐานยังไม่พอ

พูด/เขียนได้หลายแบบ

FORMAL

Please ensure that the mass-production release is fully verified against the approved requirements for trial acceptance, capability, and unresolved risks before release.

CASUAL

Can we check the mass-production release and close the remaining points on trial acceptance, capability, and unresolved risks?

ALTERNATIVE

For the mass-production release, confirm the latest revision, the cut-in point, validation evidence, and any open risk before release.

Grammar Reference

Present Simple for Process FactsPresent Simple สำหรับข้อเท็จจริงและขั้นตอนงาน · Subject + base verb(s/es)Present Perfect for Completed Work with Current ImpactPresent Perfect สำหรับสิ่งที่ทำเสร็จและมีผลถึงปัจจุบัน · Subject + have/has + past participle Past Simple for Incident ReportingPast Simple สำหรับรายงานเหตุการณ์ที่เกิดแล้ว · Subject + past verb

แกะรูปประโยค

ใช้ประโยคนี้อย่างไร

พูด/เขียนได้หลายแบบ

Grammar Reference

ประโยคใกล้เคียง

Do not release the mass-production release until the latest revision, cut-in point, validation evidence, and open risks have been reviewed with the responsible functions.

Before the next release, verify the controls for trial acceptance, capability, and unresolved risks in the mass-production release.

The team is reviewing the controls for trial acceptance, capability, and unresolved risks as part of the mass-production release.

If the mass-production release is not closed before the next build, the unresolved points around trial acceptance, capability, and unresolved risks may create a production or quality risk.

We have completed the initial review of the mass-production release and assigned owners for the remaining actions related to trial acceptance, capability, and unresolved risks.

Could you clarify how the controls for trial acceptance, capability, and unresolved risks will be verified and who will approve the mass-production release?

We would appreciate it if you could provide the latest evidence for the mass-production release, including the status of trial acceptance, capability, and unresolved risks, by 3 p.m. today.

For management review, the main open point in the mass-production release is the control of trial acceptance, capability, and unresolved risks; the immediate risk is contained, and the team is working toward final closure.